Study Recruitment

    

Measurement of ART Drug Concentrations in Brain by 19f-MRS as an Indicator of Neurotoxicity

Status: Enrolling

Summary:

Participate in a one-time research visit looking at the effects of your current HIV medication

and your brain.

Study visit consists of:

  • A brief medical interview
  • A blood draw
  • An MRI

Visit lasts about 4 hours.

Compensation of $120

Transportation provided (within San Diego County)

You may qualify if you are taking any of the following HIV medications*:

  • Pifeltro (Doravirine)
  • Emtriva (Emtricitabine)
  • Tivicay, Juluca (Dolutegravir)

For further details regarding this study, or other studies, please call (619) 543-5000 and ask to speak with a recruiter.

 

*All information collected is kept strictly confidential.  Not all individuals are eligible to participate.

 

 

Copyright ©2022 HIV Neurobehavioral Research Program | University of California, San Diego
For questions regarding this site, please contact the webmaster